相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Emerging markers of inflammation and oxidative stress as potential predictors of coronary artery disease
George Tsirebolos et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2023)
Soluble receptor for advanced glycation end products protects from ischemia- and reperfusion-induced acute kidney injury
Taro Miyagawa et al.
BIOLOGY OPEN (2022)
Circulating levels of AGEs and soluble RAGE isoforms are associated with all-cause mortality and development of cardiovascular complications in type 2 diabetes: a retrospective cohort study
Jacopo Sabbatinelli et al.
CARDIOVASCULAR DIABETOLOGY (2022)
Effects of RAGE Deletion on the Cardiac Transcriptome during Aging
Francesco Scavello et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Targeting fibrosis, mechanisms and cilinical trials
Manyu Zhao et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2022)
P-selectin targeted RAGE-shRNA lipoplexes alleviate atherosclerosis-associated inflammation
Cristina Ana Mocanu et al.
JOURNAL OF CONTROLLED RELEASE (2021)
Epigenetic alterations of TGFβ and its main canonical signaling mediators in the context of cardiac fibrosis
Luis Algeciras et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2021)
Small-molecule antagonism of the interaction of the RAGE cytoplasmic domain with DIAPH1 reduces diabetic complications in mice
Michaele B. Manigrasso et al.
SCIENCE TRANSLATIONAL MEDICINE (2021)
AGE/RAGE in diabetic kidney disease and ageing kidney
Xia-Qing Wu et al.
FREE RADICAL BIOLOGY AND MEDICINE (2021)
Knockout RAGE alleviates cardiac fibrosis through repressing endothelial-to-mesenchymal transition (EndMT) mediated by autophagy
Lu Zhang et al.
CELL DEATH & DISEASE (2021)
The perplexing role of RAGE in pulmonary fibrosis: causality or casualty?
Timothy N. Perkins et al.
THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE (2021)
Soluble Receptor for Advanced Glycation End-products regulates age-associated Cardiac Fibrosis
Francesco Scavello et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2021)
Increased Expression of S100B and RAGE in a Mouse Model of Bile Duct Ligation-induced Liver Fibrosis
Ji-Won Park et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2021)
The heterodimer S100A8/A9 is a potent therapeutic target for idiopathic pulmonary fibrosis
Kota Araki et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2021)
Serum high-mobility group box 1 is associated with the onset and severity of acute exacerbation of idiopathic pulmonary fibrosis
Kakuhiro Yamaguchi et al.
RESPIROLOGY (2020)
RAGE and its ligands: from pathogenesis to therapeutics
Nitish Jangde et al.
CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY (2020)
The Gly82Ser mutation in AGER contributes to pathogenesis of pulmonary fibrosis in combined pulmonary fibrosis and emphysema (CPFE) in Japanese patients
Takumi Kinjo et al.
SCIENTIFIC REPORTS (2020)
Fibrosis: from mechanisms to medicines
Neil C. Henderson et al.
NATURE (2020)
Reduced endogenous secretory RAGE in blood and bronchoalveolar lavage fluid is associated with poor prognosis in idiopathic pulmonary fibrosis
Kakuhiro Yamaguchi et al.
RESPIRATORY RESEARCH (2020)
Is there any evidence that AGE/sRAGE is a universal biomarker/risk marker for diseases?
Kailash Prasad
MOLECULAR AND CELLULAR BIOCHEMISTRY (2019)
5-Fluorouracil Induces Enteric Neuron Death and Glial Activation During Intestinal Mucositis via a S100B-RAGE-NFκB-Dependent Pathway
Deiziane V. S. Costa et al.
SCIENTIFIC REPORTS (2019)
Soluble receptor for AGE in diabetic nephropathy and its progression in Finnish individuals with type 1 diabetes
Jenny M. Waden et al.
DIABETOLOGIA (2019)
Effect of Irbesartan on AGEs-RAGE and MMPs systems in rat type 2 diabetes myocardial-fibrosis model
Ye Hongwei et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2019)
Cardiac fibrosis - A short review of causes and therapeutic strategies
Svenja Hinderer et al.
ADVANCED DRUG DELIVERY REVIEWS (2019)
Modeling Steatohepatitis in Humans with Pluripotent Stem Cell-Derived Organoids
Rie Ouchi et al.
CELL METABOLISM (2019)
The Modern Western Diet Rich in Advanced Glycation End-Products (AGEs): An Overview of Its Impact on Obesity and Early Progression of Renal Pathology
Arianna Bettiga et al.
NUTRIENTS (2019)
HMGB1 and SEPP1 as predictors of hepatocellular carcinoma in patients with viral C hepatitis: Effect of DAAs
Nehal Rizk et al.
CLINICAL BIOCHEMISTRY (2019)
Pharmacotherapy and adjunctive treatment for idiopathic pulmonary fibrosis (IPF)
Shigeki Saito et al.
JOURNAL OF THORACIC DISEASE (2019)
Integral role of receptor for advanced glycation end products (RAGE) in nondiabetic atherosclerosis
Hironori Uekita et al.
FUKUSHIMA JOURNAL OF MEDICAL SCIENCE (2019)
Self-assisted membrane-penetrating helical polypeptides mediate anti-inflammatory RNAi against myocardial ischemic reperfusion (IR) injury
Qiujun Liang et al.
BIOMATERIALS SCIENCE (2019)
Targeting RAGE Signaling in Inflammatory Disease
Barry I. Hudson et al.
ANNUAL REVIEW OF MEDICINE, VOL 69 (2018)
S100A8/A9 promotes parenchymal damage and renal fibrosis in obstructive nephropathy
A. Tammaro et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2018)
RAGE Deletion Confers Renoprotection by Reducing Responsiveness to Transforming Growth Factor-beta and Increasing Resistance to Apoptosis
Shinji Hagiwara et al.
DIABETES (2018)
Therapeutic effects of recombinant human S100A6 and soluble receptor for advanced glycation end products(sRAGE) on CCl4-induced liver fibrosis in mice
Peng Xia et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2018)
Extracellular HMGB1 as a therapeutic target in inflammatory diseases
Ulf Andersson et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2018)
High Mobility Group Box-1 Drives Fibrosis Progression Signaling via the Receptor for Advanced Glycation End Products in Mice
Xiaodong Ge et al.
HEPATOLOGY (2018)
High-mobility group box 1 induces endoplasmic reticulum stress and activates hepatic stellate cells
Qin He et al.
LABORATORY INVESTIGATION (2018)
Serum levels of advanced glycation end-products (AGEs) and the decoy soluble receptor for AGEs (sRAGE) can identify non-alcoholic fatty liver disease in age-, sex- and BMI-matched normo-glycemic adults
Susana A. Palma-Duran et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2018)
AGEs, RAGEs and s-RAGE; friend or foe for cancer
Saheem Ahmad et al.
SEMINARS IN CANCER BIOLOGY (2018)
High-mobility group box 1 protein (HMGB1) operates as an alarmin outside as well as inside cells
Ulf Andersson et al.
SEMINARS IN IMMUNOLOGY (2018)
Blockade of HMGB1 Attenuates Diabetic Nephropathy in Mice
Xiaochen Chen et al.
SCIENTIFIC REPORTS (2018)
Uremic Advanced Glycation End Products and Protein-Bound Solutes Induce Endothelial Dysfunction Through Suppression of Kruppel-Like Factor 2
Keith Saum et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2018)
Role of Advanced Glycation End Products in Carcinogenesis and their Therapeutic Implications
David Schroeter et al.
CURRENT PHARMACEUTICAL DESIGN (2018)
Serum AGE/RAGEs as potential biomarker in idiopathic pulmonary fibrosis
Carlos Machahua et al.
RESPIRATORY RESEARCH (2018)
Targeting the Receptor for Advanced Glycation Endproducts (RAGE): A Medicinal Chemistry Perspective
Salvatore Bongarzone et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Homeostatic nuclear RAGE-ATM interaction is essential for efficient DNA repair
Varun Kumar et al.
NUCLEIC ACIDS RESEARCH (2017)
AGER gene polymorphisms and soluble receptor for advanced glycation end product in patients with idiopathic pulmonary fibrosis
Kakuhiro Yamaguchi et al.
RESPIROLOGY (2017)
SUPPRESSED MMP-9 ACTIVITY IN MYOCARDIAL INFARCTION-RELATED CARDIOGENIC SHOCK IMPLIES DIMINISHED RAGE DEGRADATION
Simina-Ramona Selejan et al.
SHOCK (2017)
Jiangtang decoction ameliorate diabetic nephropathy through the regulation of PI3K/Akt-mediated NF-κB pathways in KK-Ay mice
Jin-Ni Hong et al.
CHINESE MEDICINE (2017)
Classification and Differential Diagnosis of Diabetic Nephropathy
Chenyang Qi et al.
JOURNAL OF DIABETES RESEARCH (2017)
Circulating soluble RAGE isoforms are attenuated in obese, impaired-glucose-tolerant individuals and are associated with the development of type 2 diabetes
Edwin R. Miranda et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2017)
Plasma Soluble Receptor for Advanced Glycation End Products in Idiopathic Pulmonary Fibrosis
Ani Manichaikul et al.
ANNALS OF THE AMERICAN THORACIC SOCIETY (2017)
Hepatic stellate cells as key target in liver fibrosis
Takaaki Higashi et al.
ADVANCED DRUG DELIVERY REVIEWS (2017)
RAGE-Aptamer Blocks the Development and Progression of Experimental Diabetic Nephropathy
Takanori Matsui et al.
DIABETES (2017)
Advanced Glycation End Products, Oxidation Products, and the Extent of Atherosclerosis During the VA Diabetes Trial and Follow-up Study
Aramesh Saremi et al.
DIABETES CARE (2017)
Blockade of receptor for advanced glycation end products protects against systolic overload-induced heart failure after transverse aortic constriction in mice
Yu Liu et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2016)
Therapeutic effects of antigen affinity-purified polyclonal anti-receptor of advanced glycation end-product (RAGE) antibodies on cholestasis-induced liver injury in rats
Peng Xia et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2016)
Keeping the senescence secretome under control: Molecular reins on the senescence-associated secretory phenotype
Nicolas Malaquin et al.
EXPERIMENTAL GERONTOLOGY (2016)
Atrial tissue expression of receptor for advanced glycation end-products (RAGE) and atrial fibrosis in patients with mitral valve disease
Pil-Sung Yang et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2016)
Atorvastatin prevents advanced glycation end products (AGEs)-induced cardiac fibrosis via activating peroxisome proliferator-activated receptor gamma (PPAR-γ)
Miao Chen et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2016)
AGEs/sRAGE, a novel risk factor in the pathogenesis of end-stage renal disease
Kailash Prasad et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2016)
RAGE axis in neuroinflammation, neurodegeneration and its emerging role in the pathogenesis of amyotrophic lateral sclerosis
Rashmi Ray et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2016)
RAGE and TGF-β1 Cross-Talk Regulate Extracellular Matrix Turnover and Cytokine Synthesis in AGEs Exposed Fibroblast Cells
Andreea Iren Serban et al.
PLOS ONE (2016)
Advanced glycation end product (AGE)-induced hepatic stellate cell activation via autophagy contributes to hepatitis C-related fibrosis
YingLi He et al.
ACTA DIABETOLOGICA (2015)
HMGB1 Enhances the AGE-Induced Expression of CTGF and TGF-β via RAGE-Dependent Signaling in Renal Tubular Epithelial Cells
Meichu Cheng et al.
AMERICAN JOURNAL OF NEPHROLOGY (2015)
Acrylamide induces accelerated endothelial aging in a human cell model
Cyril Sellier et al.
FOOD AND CHEMICAL TOXICOLOGY (2015)
Phosphatidylserine and the human brain
Michael J. Glade et al.
NUTRITION (2015)
Decreased plasma endogenous soluble RAGE, and enhanced adipokine secretion, oxidative stress and platelet/coagulative activation identify non-alcoholic fatty liver disease among patients with familial combined hyperlipidemia and/or metabolic syndrome
Francesca Santilli et al.
VASCULAR PHARMACOLOGY (2015)
Inhibitory effect of receptor for advanced glycation end product-specific small interfering RNAs on the development of hepatic fibrosis in primary rat hepatic stellate cells
Jin-Rong Xia et al.
MOLECULAR MEDICINE REPORTS (2015)
RAGE and its ligands in cancer - culprits, biomarkers, or therapeutic targets?
P. Tesarova et al.
NEOPLASMA (2015)
Involvement of the nuclear high mobility group B1 peptides released from injured hepatocytes in murine hepatic fibrogenesis
Ying-Hsien Kao et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2014)
Macrophage endocytosis of high-mobility group box 1 triggers pyroptosis
J. Xu et al.
CELL DEATH AND DIFFERENTIATION (2014)
DIETARY GLYCOTOXINS EXACERBATE PROGRESSION OF EXPERIMENTAL FATTY LIVER DISEASE
C. Leung et al.
JOURNAL OF HEPATOLOGY (2014)
Anti-fibrotic effects of specific-siRNA targeting of the receptor for advanced glycation end products in a rat model of experimental hepatic fibrosis
Xiao-Gang Cai et al.
MOLECULAR MEDICINE REPORTS (2014)
The HMGB1/RAGE inflammatory pathway promotes pancreatic tumor growth by regulating mitochondrial bioenergetics
R. Kang et al.
ONCOGENE (2014)
Wound repair and regeneration: Mechanisms, signaling, and translation
Sabine A. Eming et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Role of advanced glycation end products in cellular signaling
Christiane Ott et al.
REDOX BIOLOGY (2014)
Advanced glycation end products accelerate rat vascular calcification through RAGE/oxidative stress
Qin Wei et al.
BMC CARDIOVASCULAR DISORDERS (2013)
Cellular signalling of the receptor for advanced glycation end products (RAGE)
Jianling Xie et al.
CELLULAR SIGNALLING (2013)
S100A9 promotes human lung fibroblast cells activation through receptor for advanced glycation end-product-mediated extracellular-regulated kinase 1/2, mitogen-activated protein-kinase and nuclear factor-B-dependent pathways
X. Xu et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2013)
HMGB1 in Cancer: Good, Bad, or Both?
Rui Kang et al.
CLINICAL CANCER RESEARCH (2013)
Functions of S100 Proteins
R. Donato et al.
CURRENT MOLECULAR MEDICINE (2013)
Receptor for Advanced Glycation Endproducts (RAGE) Is a Key Regulator of Oval Cell Activation and Inflammation-Associated Liver Carcinogenesis in Mice
Tobias Pusterla et al.
HEPATOLOGY (2013)
RAGE inhibits human respiratory syncytial virus syncytium formation by interfering with F-protein function
Jane Tian et al.
JOURNAL OF GENERAL VIROLOGY (2013)
RAGE regulation and signaling in inflammation and beyond
Katrin Kierdorf et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2013)
RAGE-mediated interstitial fibrosis in neonatal obstructive nephropathy is independent of NF-κB activation
Mojca Gasparitsch et al.
KIDNEY INTERNATIONAL (2013)
Invasion potential of H22 hepatocarcinoma cells is increased by HMGB1-induced tumor NF-κB signaling via initiation of HSP70
Wei Gong et al.
ONCOLOGY REPORTS (2013)
Alternative Splicing of the RAGE Cytoplasmic Domain Regulates Cell Signaling and Function
Joel Jules et al.
PLOS ONE (2013)
Curcumin inhibits gene expression of receptor for advanced glycation end-products (RAGE) in hepatic stellate cells in vitro by elevating PPARγ activity and attenuating oxidative stress
Jianguo Lin et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
RAGE binds C1q and enhances C1q-mediated phagocytosis
Wanchao Ma et al.
CELLULAR IMMUNOLOGY (2012)
Lysophosphatidic acid targets vascular and oncogenic pathways via RAGE signaling
Vivek Rai et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
RAGE Expression in Human T Cells: A Link between Environmental Factors and Adaptive Immune Responses
Eitan M. Akirav et al.
PLOS ONE (2012)
S100A9 in BALF is a candidate biomarker of idiopathic pulmonary fibrosis
Atsuko Hara et al.
RESPIRATORY MEDICINE (2012)
Glycer-AGEs-RAGE signaling enhances the angiogenic potential of hepatocellular carcinoma by upregulating VEGF expression
Junichi Takino et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2012)
PF-04494700, an Oral Inhibitor of Receptor for Advanced Glycation End Products (RAGE), in Alzheimer Disease
Marwan N. Sabbagh et al.
ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2011)
Interplay between RAGE, CD44, and focal adhesion molecules in epithelial-mesenchymal transition of alveolar epithelial cells
Stephen T. Buckley et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2011)
Receptor for AGE (RAGE): signaling mechanisms in the pathogenesis of diabetes and its complications
Ravichandran Ramasamy et al.
YEAR IN DIABETES AND OBESITY (2011)
Total Soluble and Endogenous Secretory Receptor for Advanced Glycation End Products as Predictive Biomarkers of Coronary Heart Disease Risk in Patients With Type 2 Diabetes An Analysis From the CARDS Trial
Helen M. Colhoun et al.
DIABETES (2011)
Alternative splicing of RAGE: roles in biology and disease
Anastasia Z. Kalea et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2011)
Involvement of Membrane Type 1-Matrix Metalloproteinase (MT1-MMP) in RAGE Activation Signaling Pathways
Masashi Kamioka et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2011)
Septic Shock Is Associated with Receptor for Advanced Glycation End Products Ligation of LPS
Yasuhiko Yamamoto et al.
JOURNAL OF IMMUNOLOGY (2011)
S100B alters neuronal survival and dendrite extension via RAGE-mediated NF-κB signaling
Alejandro Villarreal et al.
JOURNAL OF NEUROCHEMISTRY (2011)
NF-κB in the liver-linking injury, fibrosis and hepatocellular carcinoma
Tom Luedde et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2011)
Advanced glycation endproducts and their receptor RAGE in Alzheimer's disease
Velandai Srikanth et al.
NEUROBIOLOGY OF AGING (2011)
AGEs increased migration and inflammatory responses of adventitial fibroblasts via RAGE, MAPK and NF-kappa B pathways
YaYang Liu et al.
ATHEROSCLEROSIS (2010)
The 1.5 Å Crystal Structure of Human Receptor for Advanced Glycation Endproducts (RAGE) Ectodomains Reveals Unique Features Determining Ligand Binding
HaJeung Park et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
The Receptor for Advanced Glycation End Products (RAGE) and the Lung
Stephen T. Buckley et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2010)
Advanced Glycation End-Products Induce Tubular CTGF via TGF-β-Independent Smad3 Signaling
Arthur C. K. Chung et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
The Role of the Receptor for Advanced Glycation End-Products in a Murine Model of Silicosis
Lasse Ramsgaard et al.
PLOS ONE (2010)
Gene Expression Profiles of Acute Exacerbations of Idiopathic Pulmonary Fibrosis
Kazuhisa Konishi et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2009)
Binding of S100 proteins to RAGE: An update
Estelle Leclerc et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2009)
RAGE mediates oxidized LDL-induced pro-inflammatory effects and atherosclerosis in non-diabetic LDL receptor-deficient mice
Li Sun et al.
CARDIOVASCULAR RESEARCH (2009)
RAGE: a novel biological and genetic marker for vascular disease
Anastasia Z. Kalea et al.
CLINICAL SCIENCE (2009)
Controversial role of RAGE in the pathogenesis of idiopathic pulmonary fibrosis
E. Bargagli et al.
RESPIRATORY PHYSIOLOGY & NEUROBIOLOGY (2009)
Low levels of soluble receptor for advanced glycation end products in non-ST elevation myocardial infarction patients
Erick D. McNair et al.
INTERNATIONAL JOURNAL OF ANGIOLOGY (2009)
A role for the receptor for advanced glycation end products in idiopathic pulmonary fibrosis
Judson M. Englert et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
Loss of RAGE in pulmonary fibrosis -: Molecular relations to functional changes in pulmonary cell types
Markus A. Queisser et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2008)
The role of high mobility group box1 in pulmonary fibrosis
Naoki Hamada et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2008)
Receptor for advanced glycation end products (RAGE) deficiency attenuates the development of atherosclerosis in diabetes
Aino Soro-Paavonen et al.
DIABETES (2008)
Identification, classification, and expression of RAGE gene splice variants
Barry I. Hudson et al.
FASEB JOURNAL (2008)
A soluble form of the receptor for advanced glycation endproducts (RAGE) is produced by proteolytic cleavage of the membrane-bound form by the sheddase a disintegrin and metalloprotease 10 (ADAM10)
Angela Raucci et al.
FASEB JOURNAL (2008)
Specific siRNA targeting the receptor for advanced glycation end products inhibits experimental hepatic fibrosis in rats
Jin-Rong Xia et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2008)
Receptor for Advanced Glycation End Products Is Subjected to Protein Ectodomain Shedding by Metalloproteinases
Ling Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Interaction of the RAGE Cytoplasmic Domain with Diaphanous-1 Is Required for Ligand-stimulated Cellular Migration through Activation of Rac1 and Cdc42
Barry I. Hudson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Vascular and inflammatory stresses mediate atherosclerosis via RAGE and its ligands in apoE(-/-) mice
Evis Harja et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Advanced glycation end products enhance the proliferation and activation of hepatic stellate cells
Keiko Iwamoto et al.
JOURNAL OF GASTROENTEROLOGY (2008)
Cellular and molecular mechanisms of fibrosis
T. A. Wynn
JOURNAL OF PATHOLOGY (2008)
Promotion of cell adherence and spreading: a novel function of RAGE, the highly selective differentiation marker of human alveolar epithelial type I cells
N Demling et al.
CELL AND TISSUE RESEARCH (2006)
Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation
R Ramasamy et al.
GLYCOBIOLOGY (2005)
Receptor for advanced glycation end-products is a marker of type I lung alveolar cells
M Shirasawa et al.
GENES TO CELLS (2004)
The pattern recognition receptor (RAGE) is a counterreceptor for leukocyte integrins: A novel pathway for inflammatory cell recruitment
T Chavakis et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brain
R Deane et al.
NATURE MEDICINE (2003)
RAGE drives the development of glomerulosclerosis and implicates podocyte activation in the pathogenesis of diabetic nephropathy
TM Wendt et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury
H Yonekura et al.
BIOCHEMICAL JOURNAL (2003)
Release of chromatin protein HMGB1 by necrotic cells triggers inflammation
P Scaffidi et al.
NATURE (2002)
Up-regulated expression of the receptor for advanced glycation end products in cultured rat hepatic stellate cells during transdifferentiation to myofibroblasts
H Fehrenbach et al.
HEPATOLOGY (2001)
分享论文
